Home > Sciences De La Vie > Industrie Pharmaceutique > Thérapies > MarketWatch: CNS
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Thérapies > Etude de marché sectorielle
 MarketWatch: CNS
€ 170,00
Editeur :
Datamonitor
Langue :
Anglais
Date de publication :
Octobre 2005
Taille du document :
29
Autres informations :
Description , Table des matières
 
Recevez cette publication aujourd'hui !
Plus d'information ?
09 70 463 423
 
Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
Top CNS Portfolios in 2004 - The Industry Gold Standards
57 pages | Janvier 2005 |
IntroductionThe market for central nervous system prescription drugs grew 21.3% to reach $62.4 billion in 2003.
The growth of this massive market is due to companies accessing previously untapped p
1 520,00 €
 
 
Stakeholder Opinions: Primary Brain Cancer - Temozolomide Turns Heads
144 pages | Juillet 2005 |
IntroductionThe incidence of glioblastoma is increasing.
Schering-Plough's temozolomide has gained approval as first line therapy for glioblastoma and has provided some survival benefit.
However
3 040,00 €
 
 
MarketWatch: Cancer
30 pages | Juin 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the
160,00 €
 
 
Nutraceuticals - Targeting Consumers Aged 14 –34
146 pages | Septembre 2000 |
The 14-34 age group represents approximately 30% of the total population across the 8 countries covered in the report, and as such are a key target audience.
This group is particularly critic
955,00 €
 
 
MarketWatch: CNS
28 pages | Juin 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys
160,00 €
 
 
Commercial Insight: Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
92 pages | Janvier 2005 |
IntroductionThe global cancer market is predicted to grow at a CAGR exceeding 10%.
However, a number of global and country-specific factors will support or threaten this trend including epidemiolog
12 160,00 €
 
 
MarketWatch: CNS
29 pages | Octobre 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys
170,00 €
 
 
Chinese Markets for Cancer Treatment Drugs
272 pages | Septembre 2005 |
China's demand for cancer treatmen drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's ec
2 835,00 €
 
 
The World Sleep Disorders Market, 2005-2010
87 pages | Septembre 2005 |
The sleep disorder treatment market had sales of $2.03bn in 2004.
It is dominated by one product, Ambien indicated for the short-term treatment of insomnia and providing Sanofi-Aventis with an 87%
2 219,00 €
 
 
MarketWatch: CNS
30 pages | Avril 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys
160,00 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 MarketWatch: CNS

Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the
CNS industry.


 

Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the
CNS industry.


New Search:

PPLSEN